School of Biomedical Sciences, The University of Hong Kong, Hong Kong, China.
Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China. State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, China.
Cancer Res. 2016 Oct 1;76(19):5732-5742. doi: 10.1158/0008-5472.CAN-15-3373. Epub 2016 Aug 5.
PAK4 kinase contributes to signaling pathways controlling cancer cell transformation, invasion, and survival, but its clinicopathological impact has begun to emerge only recently. Here we report that PAK4 overexpression in hepatocellular carcinoma (HCC) conveys aggressive metastatic properties. A novel nuclear splice isoform of PAK4 lacking exon 2 sequences was isolated as part of our studies. By stably overexpressing or silencing PAK4 in HCC cells, we showed that it was critical for their migration. Mechanistic investigations in this setting revealed that PAK4 directly phosphorylated p53 at S215, which not only attenuated transcriptional transactivation activity but also inhibited p53-mediated suppression of HCC cell invasion. Taken together, our results showed how PAK4 overexpression in HCC promotes metastatic invasion by regulating p53 phosphorylation. Cancer Res; 76(19); 5732-42. ©2016 AACR.
PAK4 激酶参与控制癌细胞转化、侵袭和存活的信号通路,但它的临床病理影响最近才开始显现。在这里,我们报告 PAK4 在肝细胞癌(HCC)中的过表达可传递侵袭性转移特性。作为我们研究的一部分,分离出一种新型的 PAK4 核剪接异构体,其缺乏外显子 2 序列。通过在 HCC 细胞中稳定过表达或沉默 PAK4,我们表明它对细胞迁移至关重要。在这种情况下的机制研究表明,PAK4 直接将 p53 磷酸化在 S215 位,这不仅减弱了转录激活活性,而且抑制了 p53 介导的 HCC 细胞侵袭抑制作用。总之,我们的结果表明,PAK4 在 HCC 中的过表达如何通过调节 p53 磷酸化来促进转移性侵袭。Cancer Res; 76(19); 5732-42. ©2016 AACR.